Your search history is turned on.
Date: April 1, 2015 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Christopher F. Berrigan Direct: 416.865.3065 E-mail: [email protected] April 1, 2015 FILED THROUGH SEDAR Ontario Securities Commission Alberta Securities Commission British Columbia Securities Commission The Manitoba Securities Commission Financial and Consumer Affairs Authority (Saskatchewan) ...
Microsoft Word - 22265630_1.DOCX FORM 13-502F3A CLASS 3A REPORTING ISSUERS PARTICIPATION FEE Reporting Issuer Name: Salix Pharmaceuticals, Ltd. (Class 3A reporting issuer cannot be incorporated or organized under the laws of Canada or a province or territory of Canada) Fiscal year end date: December 31, 2014 Indicate, by checking the appropriate box, whi...
printmgr file UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (RULE 14d-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 9) Salix Pharmaceuticals, Ltd. (Name of Subject Company (Issuer)) Sun Merger Sub, Inc. a wholly own...
Date: March 25, 2015 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (RULE 14d-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 8) Salix Pharmaceuticals, Ltd. (Name of Subject Company (Issuer)) Sun Merger Sub, Inc. a wholly owned subsidiary of ...
Date: March 18, 2015 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
printmgr file UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (RULE 14d-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 7) Salix Pharmaceuticals, Ltd. (Name of Subject Company (Issuer)) Sun Merger Sub, Inc. a wholly own...
Date: March 17, 2015 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (RULE 14d-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 6) Salix Pharmaceuticals, Ltd. (Name of Subject Company (Issuer)) Sun Merger Sub, Inc. a...